Trial Profile
Bioavailability study of once-daily CDT-ondansetron compared with immediate-release ondansetron
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Feb 2007
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Nausea and vomiting
- Focus Pharmacokinetics
- Sponsors SCOLR Pharma
- 08 Feb 2007 Status change
- 27 Oct 2006 New trial record.